PubRank

H Meier-Ewert

Author PubWeight™ 37.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Structure of the haemagglutinin-esterase-fusion glycoprotein of influenza C virus. Nature 1998 2.41
2 In vitro activity of norfloxacin against Chlamydia trachomatis. Eur J Clin Microbiol 1983 1.49
3 Effect of antibody to neuraminidase on the maturation and hemagglutinating activity of an influenza A2 virus. J Virol 1969 1.47
4 Isolation and structural analysis of influenza C virion glycoproteins. Virology 1981 1.17
5 Structural components of influenza C virions. J Virol 1977 1.17
6 A precursor glycoprotein in influenza C virus. Virology 1979 1.10
7 Comparative analysis of six European influenza vaccines. Eur J Clin Microbiol Infect Dis 1996 1.09
8 Time course of synthesis and assembly of influenza virus proteins. J Virol 1974 1.05
9 Studies on antigenic variations of the haemagglutinin and neuraminidase of swine influenza virus isolates. J Gen Virol 1970 1.02
10 Isolation of the influenza C virus glycoprotein in a soluble form by bromelain digestion. Virus Res 1988 0.92
11 Clinical efficacy and tolerance of fleroxacin in patients with urethritis caused by Chlamydia trachomatis. J Antimicrob Chemother 1988 0.91
12 X-ray crystallographic determination of the structure of the influenza C virus haemagglutinin-esterase-fusion glycoprotein. Acta Crystallogr D Biol Crystallogr 1999 0.88
13 A highly cytopathogenic influenza C virus variant induces apoptosis in cell culture. J Gen Virol 1997 0.88
14 Carbohydrate components of influenza C virions. J Virol 1979 0.87
15 Fusion characteristics of influenza C viruses. J Gen Virol 1990 0.87
16 Flow cytometric analysis of virus-infected cells and its potential use for screening antiviral agents. J Virol Methods 1990 0.85
17 [Immunity against poliomyelitis in the German Federal Republic (author's transl)]. Dtsch Med Wochenschr 1979 0.84
18 Inhibition of influenza C viruses by human MxA protein. Virus Res 2000 0.84
19 Genetic relatedness between influenza A (H1N1) viruses isolated from humans and pigs. J Gen Virol 1994 0.84
20 RNA'S of influenza C virus strains. Arch Virol 1979 0.84
21 Assembly of lipid-containing viruses. J Supramol Struct 1974 0.84
22 The ORF, regulated synthesis, and persistence-specific variation of influenza C viral NS1 protein. Virology 1999 0.83
23 Experimental infection with a persistent influenza C virus variant leads to prolonged genome detection in the chicken lung. Acta Virol 1996 0.82
24 [Distribution of influenza C virus infection in dogs and pigs in Bavaria]. Tierarztl Prax 1996 0.82
25 In vitro activity of ciprofloxacin against clinical isolates of Chlamydia trachomatis. Eur J Clin Microbiol 1984 0.82
26 Influenza C virus RNA is uniquely stabilized in a steady state during primary and secondary persistent infections. J Gen Virol 1996 0.81
27 The cell receptor level is reduced during persistent infection with influenza C virus. Arch Virol 1997 0.81
28 Influenza-C-virion-associated RNA-dependent RNA-polymerase activity. Biosci Rep 1984 0.80
29 Influenza C virus persistence depends on exceptional steps in viral RNA synthesis and transport. Arch Virol 1999 0.80
30 In-vitro activity of fleroxacin against Chlamydia trachomatis. J Antimicrob Chemother 1988 0.80
31 Persistent infection with an influenza C virus variant is dominantly established in the presence of the parental wild-type virus. Virus Res 1998 0.79
32 [Pathogen spectrum of urethritis in the man]. Hautarzt 1999 0.78
33 3'-Terminal sequences of influenza C virion RNA. Brief report. Arch Virol 1984 0.78
34 Oligonucleotide fingerprint analyses of influenza C virion RNA recovered from five different isolates. Arch Virol 1981 0.78
35 Nucleotide sequence analysis of the HA1 coding portion of the haemagglutinin gene of swine H1N1 influenza viruses. Virus Res 1992 0.78
36 The role of the neuraminidase of the infecting virus in the production of noninfectious (von Magnus) influenza virus. Virology 1970 0.76
37 Productive and non-productive phases during long-term persistence of influenza C virus. J Gen Virol 1993 0.76
38 Granuloma annulare and diabetes mellitus. Arch Dermatol Forsch 1971 0.75
39 Inhibition of influenza C virus replication by actinomycin D, alpha-amanitin, and UV irradiation. J Virol 1979 0.75
40 [Diagnosis and virus isolation in the hand-foot-mouth disease]. Arch Dermatol Forsch 1971 0.75
41 A timely remark on influenza. Eur J Clin Microbiol 1982 0.75
42 The persistent variant of influenza C virus carries one characteristic point mutation in RNA segment 1. Virus Res 1995 0.75
43 Isolation of H1N1 influenza virus in Munich. Infection 1979 0.75
44 Persistent influenza C virus possesses distinct functional properties due to a modified HEF glycoprotein. J Gen Virol 1994 0.75
45 [Echo-6-virus as the pathogen of hand, foot and mouth exanthema]. Hautarzt 1977 0.75
46 Nucleotide-specific PCR for molecular virus typing. J Virol Methods 1995 0.75
47 Crystallization and preliminary X-ray diffraction studies of the influenza C virus glycoprotein. Acta Crystallogr D Biol Crystallogr 1996 0.75
48 A persistent variant of influenza C virus fails to interact with actin filaments during viral assembly. Virus Res 1999 0.75
49 [Hand-foot-mouth-disease]. Munch Med Wochenschr 1971 0.75
50 [Rapid diagnosis in virus diseases]. MMW Munch Med Wochenschr 1983 0.75
51 [Epidemiologic appearance of echovirus type 6 infections]. MMW Munch Med Wochenschr 1975 0.75